Abstract:The gut microbiota has been implicated in the pathogenesis and progression of sepsis. Akkermansia muciniphila is considered to be a promising probiotic with reduced abundance in cecal ligation and puncture (CLP)-induced sepsis model, and its specific outer membrane protein (Amuc_1100) can partially recapitulate the probiotic function of Akkermansia muciniphila . However, its role in sepsis is unclear. This study aimed to investigate the effect of Amuc_1100 on the gut microbiota of septic rats, thereby improving the prognosis of septic acute lung injury (ALI). A total of 42 adult Sprague-Dawley (SD) rats were randomly divided into three groups: the sham control (SC group), the septic ALI induced by CLP method (CLP group), and administered Amuc_1100 by oral gavage (3 μg/d) for 7 d before the CLP procedure (AMUC group). The survival of the three groups was recorded and the feces and lung tissues of rats were collected 24 h after treatment for 16S rRNA sequencing and histopathological evaluation. Oral administration of Amuc_1100 improved the survival rate and alleviated lung histopathological damage induced by sepsis. Serum levels of pro-inflammatory cytokines and chemokines were substantially attenuated. Amuc_1100 significantly increased the abundance of some beneficial bacteria in septic rats. Additionally, the Firmicutes/Bacteroidetes ratio was low in septic rats, which was partially corrected by increasing Firmicutes and decreasing Bacteroidetes after oral administration of Amuc_1100 ( p < 0.05). In addition, Escherichia-Shigella , Bacteroides , and Parabacteroides were relatively enriched in septic rats, while in the AMUC group, their abundance was restored to levels similar to that of the healthy group. Amuc_1100 protects against sepsis by enhancing beneficial bacteria and reducing potential pathogenic bacteria. These findings indicate that Amuc_1100 can blunt CLP-induced ALI through the modulation of gut microbiota, thereby providing a new promising therapeutic target in sepsis.

The in Vivo Antibacterial Activity of Amoxicillin-Clavulanic Acid in Mouse Septicemia Model

Comparative Efficacy and Mechanism of Monotherapy and Combination Therapy of Bacillus licheniformis in Mice with Acute Ulcerative Colitis

Effects of Antibiotic Use on Saliva Antibody Content and Oral Microbiota in Sprague Dawley Rats

Probiotic Pre-Administration Reduces Mortality in a Mouse Model of Cecal Ligation and Puncture-Induced Sepsis.

Antibacterial Activities of Different Concentration Ratio of Cefotaxim-Sulbactam Against the Pathogenic Microorganisms

In vivo antibacterial effect of cefathiamidine against mouse septicemia

Bacteriological Efficacy of Amoxicillin/sulbactam on Acute Bacterial Infections

Vancomycin release of vancomycin-calcium sulfate and vancomycin polymethylmethacrylate in animal study

The Study on Antibacterial Activity of Amoxicillin Sulbactam Compared with Other Four Antimicrobial Agents in Vitro

Pharmacokinetics and pharmacodynemics of amoxicillin/clavulanic acid potassium in healthy volunteers

In vivo activity of antibiotic 89-07 combined with flomoxef in the experimental therapy of mouse septicemia infected by mec A gene positive MRSA

In vivo activity of cefcapene proxetil in the experimental motel of mouse septicemia infected by bacteria

Clinical Randomized Controlled Trial of Amoxycillin-sulbactam Injection in the Treatment of Bacterial Infection

Treatment effects of the combination of cefuroxime and tazobactam against mouse septicemia infected by β-lactamases producing strains

Meta-analysis of the clinical efficacy of amoxicillin-clavulanic acid formulations for acute respiratory infections in children

Study on the in vivo antimicrobial activities of clarithromycin

[Inhibitory Effect of Suramin on Inflammatory Response in Pulmonary Tissue and Peripheral Blood in LPS-induced Septic Mice].

The bacteriocin sublancin attenuates intestinal injury in young mice infected with Staphylococcus aureus

Establishment and Evaluation of a Bacteriemia Model in Mice after Infection with an Isolated Methicillin-Resistant Staphylococcus Aureus( MRSA )

A purified membrane protein from Akkermansia muciniphila blunted the sepsis-induced acute lung injury by modulation of gut microbiota in rats

Relative bioavailability of clavulanic acid/amoxicillin tablet in normal volunteers